Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline
Transfus; 58 (6), 2018
BACKGROUND
Red blood cell (RBC) transfusions remain essential in the treatment of patients with sickle cell disease (SCD) and β‐thalassemia. Alloimmunization, a well‐documented complication of transfusion, increases the risk of delayed hemolytic transfusion reactions, complicates crossmatching and i...
Anemia, Sickle Cell, Erythrocyte Transfusion/22074, Hemoglobinopathies/therapy, Transfusion Reaction/prevention & control, Transfusion Reaction, beta-Thalassemia/therapy, Anemia, Sickle Cell/therapy, Erythrocytes/metabolism, Anemia, Sickle Cell/drug therapy, Erythrocyte Transfusion, Isoantibodies/therapeutic use, Isoantigens/therapeutic use